Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-029928
Filing Date
2013-05-22
Accepted
2013-05-22 20:04:23
Documents
1
Period of Report
2013-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd380986.html 4  
1 FORM 4 rrd380986.xml 4 2834
  Complete submission text file 0001181431-13-029928.txt   4254
Mailing Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103
Business Address
MAZANET ROSEMARY (Reporting) CIK: 0001276892 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52446 | Film No.: 13866421

Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 6770 Blank Checks